EU authority EMA apparently wants to approve BioNTechs vaccine as early as 23 December

Dec 16, 2020

The following photos have been selected for you by the IMAGO picture desk on this topic. For more pictures please use the search function.

Illustration photo of the coronavirus vaccine. Helsinki Finland Copyright: xEmmixKorhonenx LKKTH20201215125531BXUZ
Illustration photo of the coronavirus vaccine. Helsinki Finland Copyright: xEmmixKorhonenx LKKTH20201215125854ORHR
Illustration photo of the coronavirus vaccine. Helsinki Finland Copyright: xEmmixKorhonenx LKKTH20201215125701ZABZ
Illustration photo of the coronavirus vaccine. Helsinki Finland Copyright: xEmmixKorhonenx LKKTH20201215125820QRFZ
Vaccine to be available 23 12 2020 Topic Image,Symbol Photo Corona Vaccine Vaccines to be available and vaccinated as early as December A disposable syringe and doses of vaccine to be injected with a needle
Vaccine to be available 23 12 2020 Topic Image,Symbol Photo Corona Vaccine Vaccines to be available and vaccinated as early as December A disposable syringe and doses of vaccine to be injected with a needle
Vaccine to be available 23 12 2020 Topic Image,Symbol Photo Corona Vaccine Vaccines to be available and vaccinated as early as December A hand wrapped in rubber gloves holds a disposable syringe and a vaccine canister containing vaccine for injection with a cannula
Biontech in Mainz, 04 12 2020 Mainz Germany Copyright: xFlorianxGaertnerx
Prof Ugur Sahin, Chairman of the Board of Biontech SE, recorded in Mainz, 04 12 2020 Mainz Germany Copyright: xFlorianxGaertnerx
Tuebingen 03 12 2020 Symbol picture The corona vaccine of the biopharmaceutical company BioNTech has been approved in Great Britain Picture for editorial use only ULMER
BIONTECH Vaccine SYMBOL IMAGE CANE PHOTO COVID 19 SARS CoV 2 VACCINE Vaccine Vaccine Cane Pictures from 22 11 2020 Meerbusch
BIONTECH Vaccine SYMBOL IMAGE CANE PHOTO COVID 19 SARS CoV 2 VACCINE Vaccine Vaccine Cane Pictures from 22 11 2020 Meerbusch
BIONTECH ZENTRALE in Mainz COVID 19 BIONTECH PFIZER SARS CoV 2 VACCINE Vaccine Vaccine 20 11 2020 in Mainz
Mainz Building of the company Biontech in Mainz, 15 11 2020 Building of the company Biontech in Mainz, 15 11 2020 Copyright: xWeissx Eibner-Pressefotox EP_rws
BIONTECH pharmaceutical company, exterior view in the twilight, Mainz 11 11 2020
Theme picture,symbol photo Corona vaccine A hand wrapped in rubber gloves holds a disposable syringe with vaccine for injection with a cannula BIONTECH Biotechnology Company
Mainz, An der Goldgrube , 26 03 2020, The companys activities focus on the development and manufacture of technologies and drugs for individualized cancer immunotherapy BioNTech SE is stepping up its global fight against the coronavirus and reports rapid progress in the development of a vaccine Mainz An der Goldgrube Rheinland Pfalz Germany
Feature Biontech 17 03 2020, Mainz Biontech, the Mainz-based specialist for immune therapies, is stepping up its global fight against the corona virus and reports rapid progress in the development of a vaccine. In the meantime, around 7000 people in Germany have contracted the virus.